Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis
Background Major psychiatric disorders are growing public health concern that attributed
14% of the global burden of diseases. The management of major psychiatric disorders is …
14% of the global burden of diseases. The management of major psychiatric disorders is …
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised …
Background Evidence of comparative benefits of long-acting injectable antipsychotics (LAIs)
versus oral antipsychotics for schizophrenia has been inconsistent across study designs …
versus oral antipsychotics for schizophrenia has been inconsistent across study designs …
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of …
These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia …
Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia …
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
Despite their widespread use, long-acting injectable (LAI) antipsychotics (APs) are often
regarded with some negativity because of the assumption of punishment, control and …
regarded with some negativity because of the assumption of punishment, control and …
Effectiveness of long-acting injectable vs oral antipsychotics in patients with schizophrenia: a meta-analysis of prospective and retrospective cohort studies
Compared with oral antipsychotics (OAPs), long-acting injectable antipsychotics (LAIs)
should improve medication adherence and reduce relapses in schizophrenia. However …
should improve medication adherence and reduce relapses in schizophrenia. However …
Prediction of disability in schizophrenia: Symptoms, cognition, and self-assessment
PD Harvey, MT Strassnig… - Journal of Experimental …, 2019 - journals.sagepub.com
Schizophrenia is associated with wide-ranging disability across multiple functional domains.
There are several determinants of disability that have been identified to date, including …
There are several determinants of disability that have been identified to date, including …
Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
JM Olivares, J Sermon, M Hemels… - Annals of general …, 2013 - Springer
Relapse in patients with schizophrenia has devastating repercussions, including worsening
symptoms, impaired functioning, cognitive deterioration and reduced quality of life. This …
symptoms, impaired functioning, cognitive deterioration and reduced quality of life. This …
Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia
G Kaplan, J Casoy, J Zummo - Patient preference and adherence, 2013 - Taylor & Francis
Schizophrenia is a debilitating chronic disease that requires lifelong medical care and
supervision. Even with treatment, the majority of patients relapse within 5 years, and suicide …
supervision. Even with treatment, the majority of patients relapse within 5 years, and suicide …
[HTML][HTML] Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs
Objective: Nonadherence is a major challenge in schizophrenia treatment. While long-acting
(depot) antipsychotic medications are often recommended to address adherence problems …
(depot) antipsychotic medications are often recommended to address adherence problems …
Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder
JA Quiroz, LN Yatham, JM Palumbo, K Karcher… - Biological …, 2010 - Elsevier
BACKGROUND: Treatment adherence is a significant problem in patients with bipolar
disorder. This study was designed to determine the efficacy of risperidone long-acting …
disorder. This study was designed to determine the efficacy of risperidone long-acting …